Aptose Biosciences(APTO) - 2022 Q4 - Earnings Call Transcript

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Conference Call March 23, 2023 5:00 PM ET Company Participants Susan Pietropaolo - Managing Director William Rice - Chairman, President and CEO Fletcher Payne - SVP and Chief Financial Officer Rafael Bejar - SVP and Chief Medical Officer Conference Call Participants Matthew Biegler - Oppenheimer Soumit Roy - Jones Trading Joe Pantginis - H.C. Wainwright Edward Tenthoff - Piper Sandler Operator Hello and thank you for standing by and welcome to Aptose Bi ...